Literature DB >> 1616363

Soluble interleukin 2 receptors in patients with polymyositis/dermatomyositis.

Y Tokano1, Y Kanai, H Hashimoto, K Okumura, S Hirose.   

Abstract

The concentration of soluble interleukin 2 receptor was determined in serum samples from 19 patients with polymyositis/dermatomyositis by an enzyme linked immunosorbent assay (ELISA). The concentration of soluble interleukin 2 receptor in serum samples from patients with polymyositis/dermatomyositis was higher than that in samples from normal subjects.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1616363      PMCID： PMC1004746          DOI： 10.1136/ard.51.6.781

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  9 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus.

Authors:  Y Tokano; A Murashima; Y Takasaki; H Hashimoto; K Okumura; S Hirose
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

3.  Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations.

Authors:  D Degiannis; J R Seibold; M Czarnecki; J Raskova; K Raska
Journal:  Arthritis Rheum       Date:  1990-03

4.  Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups.

Authors:  F W Miller; L A Love; S A Barbieri; J E Balow; P H Plotz
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

5.  Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation.

Authors:  D H Campen; D A Horwitz; F P Quismorio; G R Ehresmann; W J Martin
Journal:  Arthritis Rheum       Date:  1988-11

6.  Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity?

Authors:  N C Wood; J A Symons; G W Duff
Journal:  J Autoimmun       Date:  1988-08       Impact factor: 7.094

7.  Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.

Authors:  J A Symons; N C Wood; F S Di Giovine; G W Duff
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

8.  Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis.

Authors:  E C Keystone; K M Snow; C Bombardier; C H Chang; D L Nelson; L A Rubin
Journal:  Arthritis Rheum       Date:  1988-07

9.  Soluble interleukin-2 receptors in systemic lupus erythematosus.

Authors:  R E Wolf; W G Brelsford
Journal:  Arthritis Rheum       Date:  1988-06
  9 in total
  7 in total

Review 1.  Targeted immunotherapy trials for idiopathic inflammatory myopathies.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

Review 2.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

3.  Soluble CD4, CD8 in patients with polymyositis/dermatomyositis.

Authors:  Y Tokano; T Obara; H Hashimoto; K Okumura; S Hirose
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

4.  Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis.

Authors:  T Matsumoto; K Iwasaki
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

5.  Suppression of soluble T cell-associated proteins by an anti-interferon-α monoclonal antibody in adult patients with dermatomyositis or polymyositis.

Authors:  Xiang Guo; Brandon W Higgs; Marlon Rebelatto; Wei Zhu; Warren Greth; Yihong Yao; Lorin K Roskos; Wendy I White
Journal:  Rheumatology (Oxford)       Date:  2013-12-19       Impact factor: 7.580

6.  Soluble IL-2 receptor: a biomarker for assessing myositis activity.

Authors:  Anne Tournadre; Jean-Jacques Dubost; Martin Soubrier; Marc Ruivard; Pierre Souteyrand; Jeannot Schmidt; Pierre Clavelou; Arlette Tridon; Jean-Michel Ristori
Journal:  Dis Markers       Date:  2014-02-04       Impact factor: 3.434

7.  Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity.

Authors:  Linrong He; Xiaoming Shu; Xia Liu; Yongpeng Ge; Sizhao Li; Xin Lu; Guochun Wang
Journal:  Mediators Inflamm       Date:  2020-07-28       Impact factor: 4.711
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.